HIGHLIGHTS
- who: Aicha Assouab et al. from the Ain Chock Faculty of Sciences, Hassan II University of Casablanca, Casablanca, Morocco have published the paper: Inhibiting Human and Leishmania Arginases Using Cannabis sativa as a Potential Therapy for Cutaneous Leishmaniasis: A Molecular Docking Study, in the Journal: (JOURNAL) of 13/08/2022
- what: The aim of this study was to test Cannabis sativa`s phytochemical components (cannabinoids and terpenoids) through molecular docking against Leishmania and human arginase enzymes.
- how: The results showed that delta-9-tetrahydrocannabinol (THC) possessed the best binding energies of -6.02 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.